PCV13 is Recommended for Infants
The 13-valent pneumococcal conjugate vaccine (PCV13) is the recommended pneumococcal conjugate vaccine for routine infant immunization, administered as a 4-dose series at ages 2,4,6, and 12-15 months. 1
Standard Vaccination Schedule
For previously unvaccinated infants aged 2-6 months, the ACIP recommends:
- Primary series: 3 doses of PCV13 at approximately 8-week intervals (minimum 4 weeks between doses)
- Booster dose: Fourth dose at 12-15 months of age, at least 8 weeks after the third dose 1
Newborns should begin vaccination at 2 months of age, though the first dose can be administered as early as 6 weeks 1.
Special Populations
Premature Infants
For infants born at <37 weeks' gestation who are medically stable, administer PCV13 at the recommended chronologic age (not corrected age) concurrent with other routine vaccinations 1.
Important caveat: Apnea following intramuscular vaccination has been observed in some premature infants. Base timing decisions on the individual infant's medical status and weigh potential benefits against possible risks 1.
Late Starters (Infants Aged 7-11 Months)
If vaccination begins at 7-11 months:
- 3 total doses required
- First 2 doses: minimum 4-week interval
- Third dose: at 12-15 months, at least 8 weeks after the second dose 1
Why PCV13 Over Other Formulations
The evidence base strongly supports PCV13 for infants based on the 2010 ACIP guidelines [1-1. While newer formulations like PCV15 and PCV20 exist and show promise in recent studies 2, 3, the guideline evidence provided specifically recommends PCV13 for routine infant immunization. The 2010 ACIP recommendations represent the authoritative guidance for this population.
PCV13 provides coverage against 13 pneumococcal serotypes and has demonstrated:
- Optimal immunogenicity in infants 4
- Safety profile similar to its predecessor PCV7 1
- Effectiveness in reducing invasive pneumococcal disease 5
Key Clinical Pitfalls to Avoid
Do not delay vaccination for minor acute illness (e.g., mild upper respiratory infection, diarrhea with or without fever). Only defer vaccination for moderate or severe acute illness until the condition improves 1.
Do not restart the series if interrupted—simply continue from where you left off without adding extra doses 1.
Do not confuse PCV13 with PPSV23 (the 23-valent polysaccharide vaccine). PPSV23 is not recommended for infants and young children as it is ineffective in children <2 years of age 1.